Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemp-CBD for Chemotherapy-Induced Peripheral Neuropathy
NCT04398446Phase 2Unknown
- Sponsor
- Main Line Health
- Start
- May 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Main Line Health. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04398446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04398446.